Fertility drugs don't raise risk of uterine cancer recurrence

12/26/2012 | PhysiciansBriefing.com

Women who took fertility drugs after fertility-sparing therapy for uterine cancer were not more likely to experience recurrence than those who didn't receive fertility drugs, according to a review in the journal Obstetrics & Gynecology. Researchers looked at data on 141 patients and found a similar rate of five-year disease-free survival among women who did and didn't take fertility treatments.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA